Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Mar 29, 2013 · 10-K · 90 days after period end · 0001415889-13-000560
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $3.52M | — | — |
| Net Income | -$1.70M | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Dec 29, 2012 · filed Mar 29, 2013 · 90 d after period end
